Huo D - Search Results

1

The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions.

Miyashita M, Balogun OB, Olopade OI, Huo D. Miyashita M, et al. Among authors: huo d. Sci Rep. 2023 Feb 18;13(1):2880. doi: 10.1038/s41598-023-29888-z. Sci Rep. 2023. PMID: 36804591 Free PMC article.

2

UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women.

Hong AL, Huo D, Kim HJ, Niu Q, Fackenthal DL, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. Hong AL, et al. Among authors: huo d. Drug Metab Dispos. 2007 Aug;35(8):1254-61. doi: 10.1124/dmd.106.014183. Epub 2007 May 3. Drug Metab Dispos. 2007. PMID: 17478602

3

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.

Huo D, Kim HJ, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Niu Q, Sveen L, Fackenthal JD, Fackenthal DL, Das S, Cox N, Di Rienzo A, Olopade OI. Huo D, et al. Breast Cancer Res Treat. 2008 Jul;110(2):367-76. doi: 10.1007/s10549-007-9720-7. Epub 2007 Oct 2. Breast Cancer Res Treat. 2008. PMID: 17909964 Free PMC article.

4

Genetic testing in diverse populations: are researchers doing enough to get out the correct message?

Huo D, Olopade OI. Huo D, et al. JAMA. 2007 Dec 26;298(24):2910-1. doi: 10.1001/jama.298.24.2910. JAMA. 2007. PMID: 18159061 No abstract available.

5

Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent.

Garner CP, Ding YC, John EM, Ingles SA, Olopade OI, Huo D, Adebamowo C, Ogundiran T, Neuhausen SL. Garner CP, et al. Among authors: huo d. Hum Genet. 2008 Apr;123(3):247-55. doi: 10.1007/s00439-008-0468-x. Epub 2008 Jan 22. Hum Genet. 2008. PMID: 18210156 Free PMC article. Clinical Trial.

6

Parity and breastfeeding are protective against breast cancer in Nigerian women.

Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H, Olopade OI. Huo D, et al. Br J Cancer. 2008 Mar 11;98(5):992-6. doi: 10.1038/sj.bjc.6604275. Epub 2008 Feb 26. Br J Cancer. 2008. PMID: 18301401 Free PMC article.

7

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI. Zhang B, et al. Among authors: huo d. Fam Cancer. 2009;8(1):15-22. doi: 10.1007/s10689-008-9205-9. Epub 2008 Aug 5. Fam Cancer. 2009. PMID: 18679828

8

Advances in breast cancer: pathways to personalized medicine.

Olopade OI, Grushko TA, Nanda R, Huo D. Olopade OI, et al. Among authors: huo d. Clin Cancer Res. 2008 Dec 15;14(24):7988-99. doi: 10.1158/1078-0432.CCR-08-1211. Clin Cancer Res. 2008. PMID: 19088015 Free PMC article. Review.

9

Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.

Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Huo D, et al. J Clin Oncol. 2009 Mar 10;27(8):1184-90. doi: 10.1200/JCO.2008.17.5869. Epub 2009 Feb 2. J Clin Oncol. 2009. PMID: 19188678 Free PMC article.

10

CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.

Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J, Slamon DJ, Olopade OI. Xu J, et al. Among authors: huo d. Breast Cancer Res Treat. 2010 Apr;120(3):593-601. doi: 10.1007/s10549-009-0422-1. Epub 2009 May 23. Breast Cancer Res Treat. 2010. PMID: 19466541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

939 results

Search Page